In an attempt to discern the risk of cancer posed by certain diabetic drugs as well, the authors of a recent paper performed a systematic review and meta-analysis of all studies over the past ten years dealing with this topic.
CMS Blinks in ‘Flap’ Flap; Biomarker Testing; ‘What If’ Moment in Cancer Screening
Facing backlash from doctors, patients, and advocacy groups, the Centers for Medicare & Medicaid Services (CMS) has backed down from a proposal that would have
August 26, 2023